MarkLTykocinskiMD
Pathology • Philadelphia, PAAnatomic Pathology
Professor, Pathology, Anatomy and Cell Biology, Jefferson Medical College-Thos Jefferson Univ
Dr. Tykocinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6880Fax+1 215-349-5864
Education & Training
New York University School of MedicineClass of 1978
Certifications & Licensure
PA State Medical License 1998 - 2024
NJ State Medical License 2013 - 2023
OH State Medical License 1983 - 2005
Publications & Presentations
PubMed
- Academic Pathology's "Spiderless Network": The power of a professional society, its listserv, and its journal during a public health emergency.Mark L Tykocinski
Academic Pathology. 2022-01-01 - 7 citationsVirchow at 200 and Lown at 100 - Physicians as Activists.Salvatore Mangione, Mark L. Tykocinski
The New England Journal of Medicine. 2021-07-17 - 2 citationsToxicology and Pharmacokinetic Studies in Mice and Nonhuman Primates of the Nontoxic, Efficient, Targeted Hexameric FasL: CTLA4-FasL.Efi Makdasi, Shira Amsili, Alexandra Aronin, Tatyana B. Prigozhina, Kobi Tzdaka
Molecular Cancer Therapeutics. 2020-02-01
Press Mentions
Jefferson Names Joseph G. Cacchione, MD New CEO of Jefferson Health and Thomas Jefferson UniversityAugust 1st, 2022- Jefferson Health Makes Strides in Treating Loss of Smell and TasteMarch 2nd, 2022
- Stephen K. Klasko Announces Retirement PlansOctober 14th, 2021
- Join now to see all
Grant Support
- Cellular Cancer VaccinesNational Cancer Institute2003–2007
- Engineering Artifical Veto CellsNational Institute Of Allergy And Infectious Diseases2002–2006
- Placental Protein 14 As A Lectin-Like ImmunomodulatorFogarty International Center2003–2005
- Placental Protein 14 As A Unique ImmunoregulatorNational Institute Of Allergy And Infectious Diseases2001–2005
- Engineering Artificial Veto CellsNational Institute Of Allergy And Infectious Diseases1999–2001
- Cellular Cancer Vaccines--Gpi Protein TransferNational Cancer Institute1999–2001
- Hematopoietic Pp14--An Antiinflammatory CytokineNational Institute Of Allergy And Infectious Diseases1999–2000
- H19 In Bladder CancerNational Cancer Institute1999
- Engineering Artificial Veto CellsNational Institute Of Allergy And Infectious Diseases1997–1998
- Cellular Cancer Vaccines--Gpi Protein TransferNational Cancer Institute1997–1998
- Core--Molecular BiologyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–1998
- Hematopoietic Pp14--An Antiinflammatory CytokineNational Institute Of Allergy And Infectious Diseases1996–1998
- Protein Transfer With GPI PolypeptidesNational Institute Of Diabetes And Digestive And Kidney Diseases1996
- Cd8-Dependent ImmunoregulationNational Institute Of Allergy And Infectious Diseases1992–1996
- Human Leukemic Differentiation--Anti-Sense RNA StudiesNational Cancer Institute1988–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
